LISSA SHAFFER: Open Payments
NPI 1639856404 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 27 payments from 7 companies in 2025. Trend: 2023 $542 · 2024 $1,092 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $242 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| ABBVIE INC. | 3 | $82 |
| Exeltis, USA Inc. | 2 | $51 |
| Incyte Corporation | 1 | $21 |
| CooperSurgical, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $13 |
Products named: KISQALI, KEYTRUDA, VENCLEXTA, SLYND, EMRELIS, PLUVICTO, Fabhalta, JAKAFI.
Industry payments across NM — which companies pay providers there.
